Statines in pregnancy

Authors

  • Susana Salzberg Centenario Institute, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/diab.v56i3Sup.564

Keywords:

estatines, pregnancy

Abstract

Until a few years ago, the classification of the Food and Drug Administration (FDA) to indicate the level of risk of drugs on the fetus established five categories (A, B, C, D, X). Category X included contraindicated drugs, among which were statins. That is to say, there was a formal contraindication for statins to be used during pregnancy, or in women who could become pregnant, due to their possible teratogenic effects. Studies published after this categorization provided new data on the subject. In particular, they question the positive association between the use of statins in the embryogenic period and congenital malformations. Some studies have even shown that intrauterine exposure to statins favors prematurity and/or low birth weight.

Author Biography

Susana Salzberg, Centenario Institute, Autonomous City of Buenos Aires, Argentina

Physician, specialist in Nutrition and Diabetes; Director of the Department of Clinical Research

References

-

Published

2022-09-01

How to Cite

Salzberg, S. (2022). Statines in pregnancy. Journal of the Argentine Society of Diabetes, 56(3Sup), 67–67. https://doi.org/10.47196/diab.v56i3Sup.564

Issue

Section

6 voices in 10 minutes part 3

Most read articles by the same author(s)

1 2 > >>